These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

738 related items for PubMed ID: 11391523

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Hyperhomocysteinemia and the MTHFR C677T polymorphism promote steatosis and fibrosis in chronic hepatitis C patients.
    Adinolfi LE, Ingrosso D, Cesaro G, Cimmino A, D'Antò M, Capasso R, Zappia V, Ruggiero G.
    Hepatology; 2005 May; 41(5):995-1003. PubMed ID: 15834927
    [Abstract] [Full Text] [Related]

  • 5. The impact of steatosis on disease progression and early and sustained treatment response in chronic hepatitis C patients.
    Patton HM, Patel K, Behling C, Bylund D, Blatt LM, Vallée M, Heaton S, Conrad A, Pockros PJ, McHutchison JG.
    J Hepatol; 2004 Mar; 40(3):484-90. PubMed ID: 15123364
    [Abstract] [Full Text] [Related]

  • 6. Insulin resistance in chronic hepatitis C: association with genotypes 1 and 4, serum HCV RNA level, and liver fibrosis.
    Moucari R, Asselah T, Cazals-Hatem D, Voitot H, Boyer N, Ripault MP, Sobesky R, Martinot-Peignoux M, Maylin S, Nicolas-Chanoine MH, Paradis V, Vidaud M, Valla D, Bedossa P, Marcellin P.
    Gastroenterology; 2008 Feb; 134(2):416-23. PubMed ID: 18164296
    [Abstract] [Full Text] [Related]

  • 7. Fibrosis in genotype 3 chronic hepatitis C and nonalcoholic fatty liver disease: Role of insulin resistance and hepatic steatosis.
    Bugianesi E, Marchesini G, Gentilcore E, Cua IH, Vanni E, Rizzetto M, George J.
    Hepatology; 2006 Dec; 44(6):1648-55. PubMed ID: 17133473
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatic steatosis and insulin resistance are associated with serum imbalance of adiponectin/tumour necrosis factor-alpha in chronic hepatitis C patients.
    Durante-Mangoni E, Zampino R, Marrone A, Tripodi MF, Rinaldi L, Restivo L, Cioffi M, Ruggiero G, Adinolfi LE.
    Aliment Pharmacol Ther; 2006 Nov 01; 24(9):1349-57. PubMed ID: 17059516
    [Abstract] [Full Text] [Related]

  • 13. Insulin resistance and diabetes increase fibrosis in the liver of patients with genotype 1 HCV infection.
    Petta S, Cammà C, Di Marco V, Alessi N, Cabibi D, Caldarella R, Licata A, Massenti F, Tarantino G, Marchesini G, Craxì A.
    Am J Gastroenterol; 2008 May 01; 103(5):1136-44. PubMed ID: 18477344
    [Abstract] [Full Text] [Related]

  • 14. Steatosis and liver cell apoptosis in chronic hepatitis C: a mechanism for increased liver injury.
    Walsh MJ, Vanags DM, Clouston AD, Richardson MM, Purdie DM, Jonsson JR, Powell EE.
    Hepatology; 2004 May 01; 39(5):1230-8. PubMed ID: 15122751
    [Abstract] [Full Text] [Related]

  • 15. Contribution of obesity to hepatitis C-related fibrosis progression.
    Ortiz V, Berenguer M, Rayón JM, Carrasco D, Berenguer J.
    Am J Gastroenterol; 2002 Sep 01; 97(9):2408-14. PubMed ID: 12358265
    [Abstract] [Full Text] [Related]

  • 16. Steatohepatitis is associated with diabetes and fibrosis in genotype 1b HCV-related chronic liver disease.
    Masarone M, La Mura V, Bruno S, Gaeta GB, Vecchione R, Carrino F, Moschella F, Torella R, Persico M.
    J Viral Hepat; 2007 Oct 01; 14(10):714-20. PubMed ID: 17875006
    [Abstract] [Full Text] [Related]

  • 17. Steatosis in chronic hepatitis C: relationship to the virus and host risk factors.
    Matos CA, Perez RM, Pacheco MS, Figueiredo-Mendes CG, Lopes-Neto E, Oliveira EB, Lanzoni VP, Silva AE, Ferraz ML.
    J Gastroenterol Hepatol; 2006 Aug 01; 21(8):1236-9. PubMed ID: 16872303
    [Abstract] [Full Text] [Related]

  • 18. Leptin levels in nonalcoholic steatohepatitis and chronic hepatitis C.
    Giannini E, Botta F, Cataldi A, Tenconi GL, Ceppa P, Barreca T, Testa R.
    Hepatogastroenterology; 1999 Aug 01; 46(28):2422-5. PubMed ID: 10522010
    [Abstract] [Full Text] [Related]

  • 19. Influence of metabolic syndrome, viral genotype and antiviral therapy on superimposed fatty liver disease in chronic hepatitis C.
    Liu CJ, Jeng YM, Chen PJ, Lai MY, Yang HC, Huang WL, Kao JH, Chen DS.
    Antivir Ther; 2005 Aug 01; 10(3):405-15. PubMed ID: 15918331
    [Abstract] [Full Text] [Related]

  • 20. Influence of insulin resistance on hepatic fibrosis and steatosis in hepatitis C virus (HCV) mono-infected compared with HIV-HCV co-infected patients.
    Halfon P, Pénaranda G, Carrat F, Bedossa P, Bourlière M, Ouzan D, Renou C, Tran A, Rosenthal E, Wartelle C, Delasalle P, Cacoub P.
    Aliment Pharmacol Ther; 2009 Jul 01; 30(1):61-70. PubMed ID: 19292832
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 37.